- Home
- LAES vs RDHL Comparison
LAES vs RDHL Comparison
Compare LAES & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- RDHL
- Stock Information
- Founded
- LAES 2022
- RDHL 2009
- Country
- LAES Switzerland
- RDHL Israel
- Employees
- LAES N/A
- RDHL N/A
- Industry
- LAES Semiconductors
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- RDHL Health Care
- Exchange
- LAES Nasdaq
- RDHL Nasdaq
- Market Cap
- LAES 304.2M
- RDHL 4.3M
- IPO Year
- LAES N/A
- RDHL N/A
- Fundamental
- Price
- LAES $3.69
- RDHL $2.15
- Analyst Decision
- LAES Strong Buy
- RDHL
- Analyst Count
- LAES 1
- RDHL 0
- Target Price
- LAES $6.00
- RDHL N/A
- AVG Volume (30 Days)
- LAES 10.5M
- RDHL 18.4K
- Earning Date
- LAES 07-22-2025
- RDHL 08-28-2025
- Dividend Yield
- LAES N/A
- RDHL N/A
- EPS Growth
- LAES N/A
- RDHL N/A
- EPS
- LAES N/A
- RDHL N/A
- Revenue
- LAES $10,981,000.00
- RDHL $8,042,999.00
- Revenue This Year
- LAES N/A
- RDHL $381.91
- Revenue Next Year
- LAES N/A
- RDHL N/A
- P/E Ratio
- LAES N/A
- RDHL N/A
- Revenue Growth
- LAES N/A
- RDHL 23.17
- 52 Week Low
- LAES $0.29
- RDHL $1.71
- 52 Week High
- LAES $11.00
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- LAES 51.82
- RDHL 64.10
- Support Level
- LAES $3.72
- RDHL $2.00
- Resistance Level
- LAES $4.28
- RDHL $2.08
- Average True Range (ATR)
- LAES 0.32
- RDHL 0.09
- MACD
- LAES -0.05
- RDHL 0.03
- Stochastic Oscillator
- LAES 37.05
- RDHL 100.00
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.